A Japanese panel of experts gave the green light for the health minister to approve the production and sale of Daiichi Sankyo's vaccine for measles, mumps and rubella. https://www.japantimes.co.jp/news/2026/03/03/japan/science-health/mmr-vaccine-ok-expert-panel/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #daiichisankyo #vaccinations #health #covid19 #medicine

Daiichi Sankyo said it would start over-the-counter sales of an emergency contraceptive pill on Feb. 2, marking the first time that such a pill will be sold without a prescription in Japan. https://www.japantimes.co.jp/news/2025/12/18/japan/science-health/japan-otc-emergency-contraception/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #pharmaceutical #health #pregnancy #birthcontrol #daiichisankyo

AstraZeneca och Daiichi Sankyo presenterar de starkaste överlevnadsdata som hittills uppnåtts för patienter med metastaserande trippelnegativ bröstcancer utan möjlighet till immunterapi. https://borsposten.se/astrazeneca-visar-genombrottsresultat-for-datroway-vid-svar-brostcancer/ #aktier #AstraZeneca #DaiichiSankyo

AstraZeneca and Daiichi Sankyo’s drug Datroway has significantly improved survival and delayed the progression of breast cancer in patients with a particularly hard to treat form of the disease, AstraZeneca has said. https://www.japantimes.co.jp/business/2025/10/07/companies/astrazeneca-breast-cancer/?utm_medium=Social&utm_source=mastodon #business #companies #astrazeneca #daiichisankyo #health #cancer #medicine #pharmaceuticals

AstraZeneca and Daiichi Sankyo’s Datroway breast cancer treatment, which the companies expect will eventually become a blockbuster, was recommended for approval in the European Union. https://www.japantimes.co.jp/business/2025/01/31/astrazeneca-daiichi-eu-approval/?utm_medium=Social&utm_source=mastodon #business #daiichisankyo #astrazeneca #cancer #medicine #pharmaceuticals #eu

Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a milestone in the company’s efforts to turn it into a widely used blockbuster. https://www.japantimes.co.jp/business/2025/01/20/companies/daiichi-sankyo-breast-cancer-treatment/?utm_medium=Social&utm_source=mastodon #business #companies #daiichisankyo #pharmaceuticals #breastcancer #us #astrazeneca

AstraZeneca and Daiichi Sankyo won U.S. approval for a novel breast cancer treatment, a milestone in the companies’ efforts to turn the medicine into a widely used blockbuster. https://www.japantimes.co.jp/business/2025/01/18/cancer-drug-astrazeneca-daiichi/?utm_medium=Social&utm_source=mastodon #business #daiichisankyo #astrazeneca #medicine #cancer #pharmaceuticals